Global Intravenous (IV) Solutions Market 2021 by Company, Regions, Type and Application, Forecast to 2026

SKU ID : GIR-18205951 | Publishing Date : 08-May-2021 | No. of pages : 82

Detailed TOC of Global Intravenous (IV) Solutions Market 2021 by Company, Regions, Type and Application, Forecast to 2026

1 Market Overview
    1.1 Product Overview and Scope of Intravenous (IV) Solutions
    1.2 Classification of Intravenous (IV) Solutions by Type
        1.2.1 Overview: Global Intravenous (IV) Solutions Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Intravenous (IV) Solutions Revenue Market Share by Type in 2020
        1.2.3 Peripheral Parenteral Nutrition
        1.2.4 Total Parenteral Nutrition
    1.3 Global Intravenous (IV) Solutions Market by Application
        1.3.1 Overview: Global Intravenous (IV) Solutions Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospital & Clinics
        1.3.3 Ambulatory
        1.3.4 Home Care
    1.4 Global Intravenous (IV) Solutions Market Size & Forecast
    1.5 Global Intravenous (IV) Solutions Market Size and Forecast by Region
        1.5.1 Global Intravenous (IV) Solutions Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Intravenous (IV) Solutions Market Size by Region, (2016-2021)
        1.5.3 North America Intravenous (IV) Solutions Market Size and Prospect (2016-2026)
        1.5.4 Europe Intravenous (IV) Solutions Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Intravenous (IV) Solutions Market Size and Prospect (2016-2026)
        1.5.6 South America Intravenous (IV) Solutions Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Intravenous (IV) Solutions Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Intravenous (IV) Solutions Market Drivers
        1.6.2 Intravenous (IV) Solutions Market Restraints
        1.6.3 Intravenous (IV) Solutions Trends Analysis
2 Company Profiles
    2.1 ICU Medical Inc. (U.S.)
        2.1.1 ICU Medical Inc. (U.S.) Details
        2.1.2 ICU Medical Inc. (U.S.) Major Business
        2.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Product and Solutions
        2.1.4 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 ICU Medical Inc. (U.S.) Recent Developments and Future Plans
    2.2 B. Braun Melsungen AG (Germany)
        2.2.1 B. Braun Melsungen AG (Germany) Details
        2.2.2 B. Braun Melsungen AG (Germany) Major Business
        2.2.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product and Solutions
        2.2.4 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 B. Braun Melsungen AG (Germany) Recent Developments and Future Plans
    2.3 Fresenius Kabi AG (Germany)
        2.3.1 Fresenius Kabi AG (Germany) Details
        2.3.2 Fresenius Kabi AG (Germany) Major Business
        2.3.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product and Solutions
        2.3.4 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Fresenius Kabi AG (Germany) Recent Developments and Future Plans
    2.4 Baxter (U.S.)
        2.4.1 Baxter (U.S.) Details
        2.4.2 Baxter (U.S.) Major Business
        2.4.3 Baxter (U.S.) Intravenous (IV) Solutions Product and Solutions
        2.4.4 Baxter (U.S.) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Baxter (U.S.) Recent Developments and Future Plans
    2.5 Amanta Healthcare (India)
        2.5.1 Amanta Healthcare (India) Details
        2.5.2 Amanta Healthcare (India) Major Business
        2.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Product and Solutions
        2.5.4 Amanta Healthcare (India) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Amanta Healthcare (India) Recent Developments and Future Plans
    2.6 Terumo Medical Corporation (Tokyo)
        2.6.1 Terumo Medical Corporation (Tokyo) Details
        2.6.2 Terumo Medical Corporation (Tokyo) Major Business
        2.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product and Solutions
        2.6.4 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Terumo Medical Corporation (Tokyo) Recent Developments and Future Plans
    2.7 Grifols S.A. (Spain)
        2.7.1 Grifols S.A. (Spain) Details
        2.7.2 Grifols S.A. (Spain) Major Business
        2.7.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Product and Solutions
        2.7.4 Grifols S.A. (Spain) Intravenous (IV) Solutions Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Grifols S.A. (Spain) Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Intravenous (IV) Solutions Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Intravenous (IV) Solutions Players Market Share
        3.2.2 Top 10 Intravenous (IV) Solutions Players Market Share
        3.2.3 Market Competition Trend
    3.3 Intravenous (IV) Solutions Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Intravenous (IV) Solutions Revenue and Market Share by Type (2016-2021)
    4.2 Global Intravenous (IV) Solutions Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Intravenous (IV) Solutions Revenue Market Share by Application (2016-2021)
    5.2 Intravenous (IV) Solutions Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Intravenous (IV) Solutions Revenue by Type (2016-2026)
    6.2 North America Intravenous (IV) Solutions Revenue by Application (2016-2026)
    6.3 North America Intravenous (IV) Solutions Market Size by Country
        6.3.1 North America Intravenous (IV) Solutions Revenue by Country (2016-2026)
        6.3.2 United States Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
        6.3.3 Canada Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
        6.3.4 Mexico Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Intravenous (IV) Solutions Revenue by Type (2016-2026)
    7.2 Europe Intravenous (IV) Solutions Revenue by Application (2016-2026)
    7.3 Europe Intravenous (IV) Solutions Market Size by Country
        7.3.1 Europe Intravenous (IV) Solutions Revenue by Country (2016-2026)
        7.3.2 Germany Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
        7.3.3 France Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
        7.3.5 Russia Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
        7.3.6 Italy Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Intravenous (IV) Solutions Revenue by Type (2016-2026)
    8.2 Asia-Pacific Intravenous (IV) Solutions Revenue by Application (2016-2026)
    8.3 Asia-Pacific Intravenous (IV) Solutions Market Size by Region
        8.3.1 Asia-Pacific Intravenous (IV) Solutions Revenue by Region (2016-2026)
        8.3.2 China Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
        8.3.3 Japan Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
        8.3.4 South Korea Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
        8.3.5 India Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
        8.3.7 Australia Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Intravenous (IV) Solutions Revenue by Type (2016-2026)
    9.2 South America Intravenous (IV) Solutions Revenue by Application (2016-2026)
    9.3 South America Intravenous (IV) Solutions Market Size by Country
        9.3.1 South America Intravenous (IV) Solutions Revenue by Country (2016-2026)
        9.3.2 Brazil Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
        9.3.3 Argentina Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Intravenous (IV) Solutions Revenue by Type (2016-2026)
    10.2 Middle East & Africa Intravenous (IV) Solutions Revenue by Application (2016-2026)
    10.3 Middle East & Africa Intravenous (IV) Solutions Market Size by Country
        10.3.1 Middle East & Africa Intravenous (IV) Solutions Revenue by Country (2016-2026)
        10.3.2 Turkey Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
        10.3.4 UAE Intravenous (IV) Solutions Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

List of Figures, Tables and Charts Available in Global Intravenous (IV) Solutions Market 2021 by Company, Regions, Type and Application, Forecast to 2026

List of Tables
    Table 1. Global Intravenous (IV) Solutions Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Intravenous (IV) Solutions Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Intravenous (IV) Solutions Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Intravenous (IV) Solutions Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Intravenous (IV) Solutions Revenue Market Share by Region (2021-2026)
    Table 6. ICU Medical Inc. (U.S.) Corporate Information, Head Office, and Major Competitors
    Table 7. ICU Medical Inc. (U.S.) Major Business
    Table 8. ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Product and Solutions
    Table 9. ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. B. Braun Melsungen AG (Germany) Corporate Information, Head Office, and Major Competitors
    Table 11. B. Braun Melsungen AG (Germany) Major Business
    Table 12. B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product and Solutions
    Table 13. B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Fresenius Kabi AG (Germany) Corporate Information, Head Office, and Major Competitors
    Table 15. Fresenius Kabi AG (Germany) Major Business
    Table 16. Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product and Solutions
    Table 17. Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Baxter (U.S.) Corporate Information, Head Office, and Major Competitors
    Table 19. Baxter (U.S.) Major Business
    Table 20. Baxter (U.S.) Intravenous (IV) Solutions Product and Solutions
    Table 21. Baxter (U.S.) Intravenous (IV) Solutions Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Amanta Healthcare (India) Corporate Information, Head Office, and Major Competitors
    Table 23. Amanta Healthcare (India) Major Business
    Table 24. Amanta Healthcare (India) Intravenous (IV) Solutions Product and Solutions
    Table 25. Amanta Healthcare (India) Intravenous (IV) Solutions Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Terumo Medical Corporation (Tokyo) Corporate Information, Head Office, and Major Competitors
    Table 27. Terumo Medical Corporation (Tokyo) Major Business
    Table 28. Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product and Solutions
    Table 29. Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Grifols S.A. (Spain) Corporate Information, Head Office, and Major Competitors
    Table 31. Grifols S.A. (Spain) Major Business
    Table 32. Grifols S.A. (Spain) Intravenous (IV) Solutions Product and Solutions
    Table 33. Grifols S.A. (Spain) Intravenous (IV) Solutions Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Global Intravenous (IV) Solutions Revenue (USD Million) by Players (2019-2021)
    Table 35. Global Intravenous (IV) Solutions Revenue Share by Players (2019-2021)
    Table 36. Breakdown of Intravenous (IV) Solutions by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 37. Intravenous (IV) Solutions Players Head Office, Products and Services Provided
    Table 38. Intravenous (IV) Solutions Mergers & Acquisitions in the Past Five Years
    Table 39. Intravenous (IV) Solutions New Entrants and Expansion Plans
    Table 40. Global Intravenous (IV) Solutions Revenue (USD Million) by Type (2016-2021)
    Table 41. Global Intravenous (IV) Solutions Revenue Share by Type (2016-2021)
    Table 42. Global Intravenous (IV) Solutions Revenue Forecast by Type (2021-2026)
    Table 43. Global Intravenous (IV) Solutions Revenue by Application (2016-2021)
    Table 44. Global Intravenous (IV) Solutions Revenue Forecast by Application (2021-2026)
    Table 45. North America Intravenous (IV) Solutions Revenue by Type (2016-2021) & (USD Million)
    Table 46. North America Intravenous (IV) Solutions Revenue by Type (2021-2026) & (USD Million)
    Table 47. North America Intravenous (IV) Solutions Revenue by Application (2016-2021) & (USD Million)
    Table 48. North America Intravenous (IV) Solutions Revenue by Application (2021-2026) & (USD Million)
    Table 49. North America Intravenous (IV) Solutions Revenue by Country (2016-2021) & (USD Million)
    Table 50. North America Intravenous (IV) Solutions Revenue by Country (2021-2026) & (USD Million)
    Table 51. Europe Intravenous (IV) Solutions Revenue by Type (2016-2021) & (USD Million)
    Table 52. Europe Intravenous (IV) Solutions Revenue by Type (2021-2026) & (USD Million)
    Table 53. Europe Intravenous (IV) Solutions Revenue by Application (2016-2021) & (USD Million)
    Table 54. Europe Intravenous (IV) Solutions Revenue by Application (2021-2026) & (USD Million)
    Table 55. Europe Intravenous (IV) Solutions Revenue by Country (2016-2021) & (USD Million)
    Table 56. Europe Intravenous (IV) Solutions Revenue by Country (2021-2026) & (USD Million)
    Table 57. Asia-Pacific Intravenous (IV) Solutions Revenue by Type (2016-2021) & (USD Million)
    Table 58. Asia-Pacific Intravenous (IV) Solutions Revenue by Type (2021-2026) & (USD Million)
    Table 59. Asia-Pacific Intravenous (IV) Solutions Revenue by Application (2016-2021) & (USD Million)
    Table 60. Asia-Pacific Intravenous (IV) Solutions Revenue by Application (2021-2026) & (USD Million)
    Table 61. Asia-Pacific Intravenous (IV) Solutions Revenue by Region (2016-2021) & (USD Million)
    Table 62. Asia-Pacific Intravenous (IV) Solutions Revenue by Region (2021-2026) & (USD Million)
    Table 63. South America Intravenous (IV) Solutions Revenue by Type (2016-2021) & (USD Million)
    Table 64. South America Intravenous (IV) Solutions Revenue by Type (2021-2026) & (USD Million)
    Table 65. South America Intravenous (IV) Solutions Revenue by Application (2016-2021) & (USD Million)
    Table 66. South America Intravenous (IV) Solutions Revenue by Application (2021-2026) & (USD Million)
    Table 67. South America Intravenous (IV) Solutions Revenue by Country (2016-2021) & (USD Million)
    Table 68. South America Intravenous (IV) Solutions Revenue by Country (2021-2026) & (USD Million)
    Table 69. Middle East & Africa Intravenous (IV) Solutions Revenue by Type (2016-2021) & (USD Million)
    Table 70. Middle East & Africa Intravenous (IV) Solutions Revenue by Type (2021-2026) & (USD Million)
    Table 71. Middle East & Africa Intravenous (IV) Solutions Revenue by Application (2016-2021) & (USD Million)
    Table 72. Middle East & Africa Intravenous (IV) Solutions Revenue by Application (2021-2026) & (USD Million)
    Table 73. Middle East & Africa Intravenous (IV) Solutions Revenue by Country (2016-2021) & (USD Million)
    Table 74. Middle East & Africa Intravenous (IV) Solutions Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Intravenous (IV) Solutions Picture
    Figure 2. Global Intravenous (IV) Solutions Revenue Market Share by Type in 2020
    Figure 3. Peripheral Parenteral Nutrition
    Figure 4. Total Parenteral Nutrition
    Figure 5. Intravenous (IV) Solutions Revenue Market Share by Application in 2020
    Figure 6. Hospital & Clinics Picture
    Figure 7. Ambulatory Picture
    Figure 8. Home Care Picture
    Figure 9. Global Intravenous (IV) Solutions Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 10. Global Intravenous (IV) Solutions Revenue and Forecast (2016-2026) & (USD Million)
    Figure 11. Global Intravenous (IV) Solutions Revenue Market Share by Region (2016-2026)
    Figure 12. Global Intravenous (IV) Solutions Revenue Market Share by Region in 2020
    Figure 13. North America Intravenous (IV) Solutions Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 14. Europe Intravenous (IV) Solutions Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 15. Asia-Pacific Intravenous (IV) Solutions Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. South America Intravenous (IV) Solutions Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. Middle East and Africa Intravenous (IV) Solutions Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Intravenous (IV) Solutions Market Drivers
    Figure 19. Intravenous (IV) Solutions Market Restraints
    Figure 20. Intravenous (IV) Solutions Market Trends
    Figure 21. ICU Medical Inc. (U.S.) Recent Developments and Future Plans
    Figure 22. B. Braun Melsungen AG (Germany) Recent Developments and Future Plans
    Figure 23. Fresenius Kabi AG (Germany) Recent Developments and Future Plans
    Figure 24. Baxter (U.S.) Recent Developments and Future Plans
    Figure 25. Amanta Healthcare (India) Recent Developments and Future Plans
    Figure 26. Terumo Medical Corporation (Tokyo) Recent Developments and Future Plans
    Figure 27. Grifols S.A. (Spain) Recent Developments and Future Plans
    Figure 28. Global Intravenous (IV) Solutions Revenue Share by Players in 2020
    Figure 29. Intravenous (IV) Solutions Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 30. Global Top 3 Players Intravenous (IV) Solutions Revenue Market Share in 2020
    Figure 31. Global Top 10 Players Intravenous (IV) Solutions Revenue Market Share in 2020
    Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 33. Global Intravenous (IV) Solutions Revenue Share by Type in 2020
    Figure 34. Global Intravenous (IV) Solutions Market Share Forecast by Type (2021-2026)
    Figure 35. Global Intravenous (IV) Solutions Revenue Share by Application in 2020
    Figure 36. Global Intravenous (IV) Solutions Market Share Forecast by Application (2021-2026)
    Figure 37. North America Intravenous (IV) Solutions Sales Market Share by Type (2016-2026)
    Figure 38. North America Intravenous (IV) Solutions Sales Market Share by Application (2016-2026)
    Figure 39. North America Intravenous (IV) Solutions Revenue Market Share by Country (2016-2026)
    Figure 40. United States Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 41. Canada Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 42. Mexico Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 43. Europe Intravenous (IV) Solutions Sales Market Share by Type (2016-2026)
    Figure 44. Europe Intravenous (IV) Solutions Sales Market Share by Application (2016-2026)
    Figure 45. Europe Intravenous (IV) Solutions Revenue Market Share by Country (2016-2026)
    Figure 46. Germany Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 47. France Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. United Kingdom Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. Russia Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Italy Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Asia-Pacific Intravenous (IV) Solutions Sales Market Share by Type (2016-2026)
    Figure 52. Asia-Pacific Intravenous (IV) Solutions Sales Market Share by Application (2016-2026)
    Figure 53. Asia-Pacific Intravenous (IV) Solutions Revenue Market Share by Region (2016-2026)
    Figure 54. China Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. Japan Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. South Korea Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. India Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Southeast Asia Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Australia Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. South America Intravenous (IV) Solutions Sales Market Share by Type (2016-2026)
    Figure 61. South America Intravenous (IV) Solutions Sales Market Share by Application (2016-2026)
    Figure 62. South America Intravenous (IV) Solutions Revenue Market Share by Country (2016-2026)
    Figure 63. Brazil Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Argentina Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. Middle East and Africa Intravenous (IV) Solutions Sales Market Share by Type (2016-2026)
    Figure 66. Middle East and Africa Intravenous (IV) Solutions Sales Market Share by Application (2016-2026)
    Figure 67. Middle East and Africa Intravenous (IV) Solutions Revenue Market Share by Country (2016-2026)
    Figure 68. Turkey Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Saudi Arabia Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. UAE Intravenous (IV) Solutions Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Keyplayers in Global Intravenous (IV) Solutions Market 2021 by Company, Regions, Type and Application, Forecast to 2026

ICU Medical Inc. (U.S.)
B. Braun Melsungen AG (Germany)
Fresenius Kabi AG (Germany)
Baxter (U.S.)
Amanta Healthcare (India)
Terumo Medical Corporation (Tokyo)
Grifols S.A. (Spain)

REQUEST SUMMARY

Request Sample

Pre-order Enquiry

Request Discount

Contact Information

24/7 Research Support

Phone: +1 424 253 0807

[email protected]